In particular, the in vitro proliferation and migration of HCC cells were more profoundly reduced by the direct targeting of MFG-E8 activity using antibodies, compared to knockdown of MFG-E8 expression using siRNA. Here, MFGE8 is linked to hepatocellular carcinoma.